Category:Annabelle Biscans

Annabelle Biscans

Executive Summary

Annabelle Biscans is an inventor who has filed 2 patents. Their primary areas of innovation include {against enzymes (viral enzymes (1 patents), {Sugars, nucleosides, nucleotides or nucleic acids} (1 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (1 patents), and they have worked with companies such as UNIVERSITY OF MASSACHUSETTS (2 patents). Their most frequent collaborators include (2 collaborations), (2 collaborations), (2 collaborations).

Patent Filing Activity

Technology Areas

List of Technology Areas

• C12N15/1137 ({against enzymes (viral enzymes): 1 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 1 patents
• A61P27/02 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/315 (of the backbone): 1 patents
• C12N2310/321 (2'-O-R Modification): 1 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2750/14122 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2750/14143 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• A61K47/554 ({the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid}): 1 patents
• A61K9/0048 (Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations): 1 patents
• A61K47/542 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/543 ({Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine}): 1 patents
• A61K47/545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K47/548 ({Phosphates or phosphonates, e.g. bone-seeking (phospholipids): 1 patents

Companies

List of Companies

• UNIVERSITY OF MASSACHUSETTS: 2 patents

Collaborators

• Claudio Punzo of Brookline MA (US) (2 collaborations)
• Anastasia Khvorova of Westborough MA (US) (2 collaborations)
• Dimas Echeverria Moreno of Worcester MA (US) (2 collaborations)
• Julia F. Alterman of Westborough MA (US) (2 collaborations)
• Matthew Hassler of Boston MA (US) (2 collaborations)
• Shun-Yun Cheng of Westborough MA (US) (2 collaborations)
• Jillian Caiazzi of Boston MA (US) (1 collaborations)